Davidv Goeddel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Davidv goeddel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Davidv Goeddel Today - Breaking & Trending Today
The Manufacturers Life Insurance Company decreased its position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Rating) by 13.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,479 shares of the company’s stock after selling 6,488 shares during the period. […] ....
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,660,000 shares, an increase of 84.6% from the March 15th total of 899,400 shares. Based on an average trading volume of 355,100 shares, the days-to-cover ratio is […] ....
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Rating) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 1,660,000 shares, an increase of 84.6% from the March 15th total of 899,400 shares. Based on an average daily trading volume, of 355,100 shares, the days-to-cover ratio […] ....
Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Rating)’s stock price traded down 2.2% during mid-day trading on Wednesday . The stock traded as low as $2.60 and last traded at $2.64. 190,059 shares changed hands during trading, a decline of 47% from the average session volume of 355,582 shares. The stock had previously closed at $2.70. […] ....
Deutsche Bank AG increased its holdings in NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Get Rating) by 53.5% in the second quarter, Holdings Channel.com reports. The firm owned 263,912 shares of the company’s stock after purchasing an additional 92,018 shares during the period. Deutsche Bank AG’s holdings in NGM Biopharmaceuticals were worth $3,384,000 at the end of […] ....